Fig. 3From: Prognostic and clinicopathological significance of SNHG20 in human cancers: a meta-analysisMeta-analysis for the pooled HRs of DFS/RFS/PFS in patients with various cancers. DFS disease-free survival, RFS recurrence-free survival, PFS progression-free survival, HR hazard ratio, 95% CI 95% confidence intervalBack to article page